Eisai Co Ltd (OTC:ESALY) and Biogen Inc (NASDAQ:BIIB) announced that three additional detailed analyses from the Phase IIb clinical study (Study 201) of…
The trial against Sam Bankman-Fried, the co-founder of FTX (CRYPTO: FTT), might face considerable delays if additional charges are brought against him, according to statements from his legal representatives.